FDA Approves Vabomere (meropenem and vaborbactam) for Complicated Urinary Tract Infections

August 29, 2017 -- The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news